Apoptotic signal transduction and T cell tolerance

References

• Kerr J, Wyllie A, Currie A. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239–257
   PubMed Web of Science ®Google Scholar
• Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P. Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol 2002; 14: 354–359
   PubMed Web of Science ®Google Scholar
• Chao DT, Korsmeyer SJ. BCL-2 family: Regulators of cell death. Annu Rev Immunol 1998; 16: 395–419
   PubMed Web of Science ®Google Scholar
• van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P. The role of mitochondrial factors in apoptosis: A Russian roulette with more than one bullet. Cell Death Differ 2002; 9: 1031–1042
   PubMed Web of Science ®Google Scholar
• Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309–1312
   PubMed Web of Science ®Google Scholar
• Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489
   PubMed Web of Science ®Google Scholar
• Smith K, Strasser A, Vaux D. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 Fas/APO-1-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease. EMBO J 1996; 15: 5167–5176
   PubMedGoogle Scholar
• Walsh C, Wen B, Chinnaiyan A, O'Rourke K, Dixit V, Hedrick S. A role for FADD in T cell activation and development. Immunity 1998; 8(4)439–449
   PubMedGoogle Scholar
• Dempsey PW, Doyle SE, He JQ, Cheng G. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14: 193–209
   PubMed Web of Science ®Google Scholar
• Medema J, Scaffidi C, Kischkel F, Shevchenko A, Mann M, Krammer P, Peter M. FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J 1997; 16(10)2794–2804
   PubMed Web of Science ®Google Scholar
• Walsh CM, Luhrs KA, Arechiga AF. The “fuzzy logic” of the death-inducing signaling complex in lymphocytes. J Clin Immunol 2003; 23: 333–353
   PubMedGoogle Scholar
• Yang X, Chang HY, Baltimore D. Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell 1998; 1: 319–325
   PubMed Web of Science ®Google Scholar
• Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998; 273: 2926–2930
   PubMed Web of Science ®Google Scholar
• MacCorkle RA, Freeman KW, Spencer DM. Synthetic activation of caspases: Artificial death switches. Proc Natl Acad Sci USA 1998; 95: 3655–3660
   PubMed Web of Science ®Google Scholar
• Siegel RM. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 2006; 6: 308–317
   PubMed Web of Science ®Google Scholar
• Dhein J, Walczak H, Baumler C, Debatin K, Krammer P. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995; 373(6513)438–441
   PubMed Web of Science ®Google Scholar
• Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997; 388: 190–195
   PubMed Web of Science ®Google Scholar
• Ju S, Panka D, Cui H, Ettinger R, el-Khatib M, Sherr D, Stanger B, Marshak-Rothstein A. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995; 373(6513)444–448
   PubMed Web of Science ®Google Scholar
• Brunner T, Mogil R, LaFace D, Yoo N, Mahboubi A, Echeverri F, Martin S, Force W, Lynch D, Ware C, et al. Cell-autonomous Fas CD95 /Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995; 373: 441–444
   PubMed Web of Science ®Google Scholar
• Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675–1687
   PubMed Web of Science ®Google Scholar
• Sprick MR, Walczak H. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 2004; 1644: 125–132
   PubMed Web of Science ®Google Scholar
• Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491–501
   PubMed Web of Science ®Google Scholar
• Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481–490
   PubMed Web of Science ®Google Scholar
• Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000; 102: 33–42
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K, Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 2001; 8: 613–621
   PubMed Web of Science ®Google Scholar
• Zheng L, Fisher G, Miller R, Peschon J, Lynch D, Lenardo M. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 1995; 377(6547)348–351
   PubMed Web of Science ®Google Scholar
• Holler N, Zaru R, Micheau O, Thome M, Attinger A, Valitutti S, Bodmer JL, Schneider P, Seed B, Tschopp J. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000; 1: 489–495
   PubMed Web of Science ®Google Scholar
• Denecker G, Vercammen D, Declercq W, Vandenabeele P. Apoptotic and necrotic cell death induced by death domain receptors. Cell Mol Life Sci 2001; 58: 356–370
   PubMed Web of Science ®Google Scholar
• Gupta S, Gollapudi S. Molecular mechanisms of TNF-alpha-induced apoptosis in aging human T cell subsets. Int J Biochem Cell Biol 2005; 37: 1034–1042
   PubMed Web of Science ®Google Scholar
• Janssen EM, Droin NM, Lemmens EE, Pinkoski MJ, Bensinger SJ, Ehst BD, Griffith TS, Green DR, Schoenberger SP. CD4+T-cell help controls CD8+T-cell memory via TRAIL-mediated activation-induced cell death. Nature 2005; 434: 88–93
   PubMed Web of Science ®Google Scholar
• Voskoboinik I, Smyth MJ, Trapani JA. Perforin-mediated target-cell death and immune homeostasis. Nat Rev Immunol 2006; 6: 940–952
   PubMed Web of Science ®Google Scholar
• Liu N, Raja SM, Zazzeroni F, Metkar SS, Shah R, Zhang M, Wang Y, Bromme D, Russin WA, Lee JC, Peter ME, Froelich CJ, Franzoso G, Ashton-Rickardt PG. NF-kappaB protects from the lysosomal pathway of cell death. EMBO J 2003; 22: 5313–5322
   PubMed Web of Science ®Google Scholar
• Matloubian M, Suresh M, Glass A, Galvan M, Chow K, Whitmire JK, Walsh CM, Clark WR, Ahmed R. A role for perforin in downregulating T-cell responses during chronic viral infection. J Virol 1999; 73: 2527–2536
   PubMedGoogle Scholar
• Stepp SE, Dufourcq-Lagelouse R, Le Deist F, Bhawan S, Certain S, Mathew PA, Henter JI, Bennett M, Fischer A, de Saint Basile G, Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 1999; 286: 1957–1959
   PubMed Web of Science ®Google Scholar
• Liu N, Phillips T, Zhang M, Wang Y, Opferman JT, Shah R, Ashton-Rickardt PG. Serine protease inhibitor 2A is a protective factor for memory T cell development. Nat Immunol 2004; 5: 919–926
   PubMedGoogle Scholar
• Zhang M, Byrne S, Liu N, Wang Y, Oxenius A, Ashton-Rickardt PG. Differential survival of cytotoxic T cells and memory cell precursors. J Immunol 2007; 178: 3483–3491
   PubMedGoogle Scholar
• Anderton SM, Wraith DC. Selection and fine-tuning of the autoimmune T-cell repertoire. Nat Rev Immunol 2002; 2: 487–498
   PubMed Web of Science ®Google Scholar
• Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002; 298: 1395–1401
   PubMed Web of Science ®Google Scholar
• Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol 2003; 4: 350–354
   PubMed Web of Science ®Google Scholar
• Nagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene. Nat Genet 1997; 17: 393–398
   PubMed Web of Science ®Google Scholar
• Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kampe O, Eskelin P, Pelto-Huikko M, Peltonen L. Aire deficient mice develop multiple features of APECED phenotype and show altered immune response. Hum Mol Genet 2002; 11: 397–409
   PubMed Web of Science ®Google Scholar
• Mathis D, Benoist C. Back to central tolerance. Immunity 2004; 20: 509–516
   PubMedGoogle Scholar
• Marrack P, Kappler J. Control of T cell viability. Annu Rev Immunol 2004; 22: 765–787
   PubMed Web of Science ®Google Scholar
• Bunin A, Khwaja FW, Kersh GJ. Regulation of Bim by TCR signals in CD4/CD8 double-positive thymocytes. J Immunol 2005; 175: 1532–1539
   PubMedGoogle Scholar
• Harada H, Quearry B, Ruiz-Vela A, Korsmeyer SJ. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc Natl Acad Sci USA 2004; 101: 15313–15317
   PubMed Web of Science ®Google Scholar
• Cante-Barrett K, Gallo EM, Winslow MM, Crabtree GR. Thymocyte negative selection is mediated by protein kinase C- and Ca2+-dependent transcriptional induction of bim [corrected]. J Immunol 2006; 176: 2299–2306
   PubMedGoogle Scholar
• Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H, Pellegrini M, Cory S, Adams JM, Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 2002; 415: 922–926
   PubMed Web of Science ®Google Scholar
• Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 2002; 3: 932–939
   PubMed Web of Science ®Google Scholar
• Strasser A, Harris AW, von Boehmer H, Cory S. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proc Natl Acad Sci USA 1994; 91: 1376–1380
   PubMedGoogle Scholar
• Linette GP, Grusby MJ, Hedrick SM, Hansen TH, Glimcher LH, Korsmeyer SJ. Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity 1994; 1: 197–205
   PubMedGoogle Scholar
• Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt FW, Thompson CB. Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci USA 1995; 92: 4763–4767
   PubMed Web of Science ®Google Scholar
• Chao DT, Korsmeyer SJ. BCL-XL-regulated apoptosis in T cell development. Int Immunol 1997; 9: 1375–1384
   PubMedGoogle Scholar
• Grillot DA, Merino R, Nunez G. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J Exp Med 1995; 182: 1973–1983
   PubMedGoogle Scholar
• Page D, Roberts E, Peschon J, Hedrick S. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J Immunol 1998; 160: 120–133
   PubMedGoogle Scholar
• Zhou T, Bluethmann H, Eldridge J, Brockhaus M, Berry K, Mountz J. Abnormal thymocyte development and production of autoreactive T cells in T cell receptor transgenic autoimmune mice. J Immunol 1991; 147(2)466–474
   PubMedGoogle Scholar
• Castro J, Listman J, Jacobson B, Wang Y, Lopez P, Ju JS, Finn P, Perkins D. Fas modulation of apoptosis during negative selection of thymocytes. Immunity 1996; 5: 617–627
   PubMedGoogle Scholar
• Kishimoto H, Sprent J. Negative selection in the thymus includes semimature T cells. J Exp Med 1997; 185(2)263–271
   PubMedGoogle Scholar
• Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, Peschon J, Chen YH. Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL − / − mice. Nat Immunol 2003; 4: 255–260
   PubMed Web of Science ®Google Scholar
• Green DR. The suicide in the thymus, a twisted trail. Nat Immunol 2003; 4: 207–208
   PubMedGoogle Scholar
• Cretney E, Uldrich AP, Berzins SP, Strasser A, Godfrey DI, Smyth MJ. Normal thymocyte negative selection in TRAIL-deficient mice. J Exp Med 2003; 198: 491–496
   PubMedGoogle Scholar
• Yue HH, Diehl GE, Winoto A. Loss of TRAIL-R does not affect thymic or intestinal tumor development in p53 and adenomatous polyposis coli mutant mice. Cell Death Differ 2005; 12: 94–97
   PubMed Web of Science ®Google Scholar
• Doerfler P, Forbush KA, Perlmutter RM. Caspase enzyme activity is not essential for apoptosis during thymocyte development. J Immunol 2000; 164: 4071–4079
   PubMedGoogle Scholar
• Woronicz JD, Calnan B, Ngo V, Winoto A. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 1994; 367: 277–281
   PubMedGoogle Scholar
• Calnan BJ, Szychowski S, Chan FK, Cado D, Winoto A. A role for the orphan steroid receptor Nur77 in apoptosis accompanying antigen-induced negative selection. Immunity 1995; 3: 273–282
   PubMedGoogle Scholar
• Cheng LE, Chan FK, Cado D, Winoto A. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis. EMBO J 1997; 16: 1865–1875
   PubMedGoogle Scholar
• Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, Mebius RE, Littman DR. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science 2000; 288: 2369–2373
   PubMed Web of Science ®Google Scholar
• Hogquist K, Jameson S, Heath W, Howard J, Bevan M, Carbone F. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17–27
   PubMed Web of Science ®Google Scholar
• Hogquist K, Jameson S, Bevan M. Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+T cells. Immunity 1995; 3: 79–86
   PubMedGoogle Scholar
• Alberola-Ila J, Hogquist K, Swan K, Bevan M, Perlmutter R. Positive and negative selection invoke distinct signaling pathways. J Exp Med 1996; 184(1)18–September
   Google Scholar
• Yablonski D, Weiss A. Mechanisms of signaling by the hematopoietic-specific adaptor proteins, SLP-76 and LAT and their B cell counterpart, BLNK/SLP-65. Adv Immunol 2001; 79: 93–128
   PubMedGoogle Scholar
• Bromley SK, Burack WR, Johnson KG, Somersalo K, Sims TN, Sumen C, Davis MM, Shaw AS, Allen PM, Dustin ML. The immunological synapse. Annu Rev Immunol 2001; 19: 375–396
   PubMed Web of Science ®Google Scholar
• Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol 2002; 2: 116–126
   PubMed Web of Science ®Google Scholar
• Diehn M, Alizadeh AA, Rando OJ, Liu CL, Stankunas K, Botstein D, Crabtree GR, Brown PO. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci USA 2002; 99: 11796–11801
   PubMed Web of Science ®Google Scholar
• Michel F, Attal-Bonnefoy G, Mangino G, Mise-Omata S, Acuto O. CD28 as a molecular amplifier extending TCR ligation and signaling capabilities. Immunity 2001; 15: 935–945
   PubMedGoogle Scholar
• Croft M. Co-stimulatory members of the TNFR family: Keys to effective T-cell immunity?. Nat Rev Immunol 2003; 3: 609–620
   PubMed Web of Science ®Google Scholar
• Song J, Salek-Ardakani S, Rogers PR, Cheng M, Van Parijs L, Croft M. The costimulation-regulated duration of PKB activation controls T cell longevity. Nat Immunol 2004
   Google Scholar
• Salek-Ardakani S, Croft M. Regulation of CD4 T cell memory by OX40 (CD134). Vaccine 2006; 24: 872–883
   PubMedGoogle Scholar
• Redmond WL, Sherman LA. Peripheral tolerance of CD8 T lymphocytes. Immunity 2005; 22: 275–284
   PubMed Web of Science ®Google Scholar
• Heissmeyer V, Rao A. E3 ligases in T cell anergy–turning immune responses into tolerance. Sci STKE 2004; 2004: pe29
   PubMedGoogle Scholar
• Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Griesser H, Mak TW. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270: 985–988
   PubMed Web of Science ®Google Scholar
• Chen W, Jin W, Tian H, Sicurello P, Frank M, Orenstein JM, Wahl SM. Requirement for transforming growth factor beta1 in controlling T cell apoptosis. J Exp Med 2001; 194: 439–453
   PubMed Web of Science ®Google Scholar
• Green DR, Droin N, Pinkoski M. Activation-induced cell death in T cells. Immunol Rev 2003; 193: 70–81
   PubMed Web of Science ®Google Scholar
• Kishimoto H, Sprent J. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+T cells. J Immunol 1999; 163: 1817–1826
   PubMedGoogle Scholar
• Mixter PF, Russell JQ, Budd RC. Delayed kinetics of T lymphocyte anergy and deletion in lpr mice. J Autoimmun 1994; 7: 697–710
   PubMedGoogle Scholar
• Russell JH, Rush B, Weaver C, Wang R. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 1993; 90: 4409–4413
   PubMed Web of Science ®Google Scholar
• Russell JH, Wang R. Autoimmune gld mutation uncouples suicide and cytokine/proliferation pathways in activated, mature T cells. Eur J Immunol 1993; 23: 2379–2382
   PubMedGoogle Scholar
• Singer G, Abbas A. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1994; 1: 365–371
   PubMed Web of Science ®Google Scholar
• Mogil RJ, Radvanyi L, Gonzalez-Quintial R, Miller R, Mills G, Theofilopoulos AN, Green DR. Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo. Int Immunol 1995; 7: 1451–1458
   PubMed Web of Science ®Google Scholar
• Suvannavejh GC, Dal Canto MC, Matis LA, Miller SD. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis. J Clin Invest 2000; 105: 223–231
   PubMed Web of Science ®Google Scholar
• Kerstan A, Hunig T. Cutting edge: Distinct TCR- and CD28-derived signals regulate CD95L, Bcl-xL, and the survival of primary T cells. J Immunol 2004; 172: 1341–1345
   PubMedGoogle Scholar
• Watanabe-Fukunaga R, Brannan C, Copeland N, Jenkins N, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356(6367)314–317
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tanaka M, Brannan C, Jenkins N, Copeland N, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76(6)969–976
   PubMed Web of Science ®Google Scholar
• Theofilopoulos AN, Balderas RS, Hang L, Dixon FJ. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice. J Exp Med 1983; 158: 901–919
   PubMedGoogle Scholar
• Lenardo MJ. Molecular regulation of T lymphocyte homeostasis in the healthy and diseased immune system. Immunol Res 2003; 27: 387–398
   PubMed Web of Science ®Google Scholar
• Lenardo MJ. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 1991; 353: 858–861
   PubMed Web of Science ®Google Scholar
• Thome M, Tschopp J. Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001; 1: 50–58
   PubMedGoogle Scholar
• Semra YK, Seidi OA, Sharief MK. Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis. J Neuroimmunol 2001; 113: 268–274
   PubMed Web of Science ®Google Scholar
• Hao Z, Hampel B, Yagita H, Rajewsky K. T cell-specific ablation of Fas leads to Fas ligand-mediated lymphocyte depletion and inflammatory pulmonary fibrosis. J Exp Med 2004; 199: 1355–1365
   Google Scholar
• Sytwu H, Liblau R, McDevitt H. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 1996; 5(1)17–30
   PubMedGoogle Scholar
• Nguyen LT, McKall-Faienza K, Zakarian A, Speiser DE, Mak TW, Ohashi PS. TNF receptor 1 (TNFR1) and CD95 are not required for T cell deletion after virus infection but contribute to peptide-induced deletion under limited conditions. Eur J Immunol 2000; 30: 683–688
   PubMedGoogle Scholar
• Mariani SM, Krammer PH. Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells. Eur J Immunol 1998; 28: 1492–1498
   PubMed Web of Science ®Google Scholar
• Jeremias I, Herr I, Boehler T, Debatin KM. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur J Immunol 1998; 28: 143–152
   PubMedGoogle Scholar
• Song K, Chen Y, Goke R, Wilmen A, Seidel C, Goke A, Hilliard B. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 2000; 191: 1095–1104
   PubMed Web of Science ®Google Scholar
• White J, Herman A, Pullen A, Kubo R, Kappler J, Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 1989; 56: 27–35
   PubMed Web of Science ®Google Scholar
• Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, Kappler J, Marrack P. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 2002; 16: 759–767
   PubMed Web of Science ®Google Scholar
• Davey GM, Kurts C, Miller JF, Bouillet P, Strasser A, Brooks AG, Carbone FR, Heath WR. Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med 2002; 196: 947–955
   PubMedGoogle Scholar
• Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847–849
   PubMed Web of Science ®Google Scholar
• Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053–1058
   PubMed Web of Science ®Google Scholar
• Nakano K, Vousden KH. PUMA a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7: 683–694
   PubMed Web of Science ®Google Scholar
• Bauer A, Villunger A, Labi V, Fischer SF, Strasser A, Wagner H, Schmid RM, Hacker G. The NF-kappaB regulator Bcl-3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc Natl Acad Sci USA 2006; 103: 10979–10984
   PubMed Web of Science ®Google Scholar
• Matzinger P. The danger model: A renewed sense of self. Science 2002; 296: 301–305
   PubMed Web of Science ®Google Scholar
• Mitchell TC, Hildeman D, Kedl RM, Teague TK, Schaefer BC, White J, Zhu Y, Kappler J, Marrack P. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol 2001; 2: 397–402
   PubMed Web of Science ®Google Scholar
• Gelman AE, Zhang J, Choi Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+T cell survival. J Immunol 2004; 172: 6065–6073
   PubMed Web of Science ®Google Scholar
• Wraith DC, Nicolson KS, Whitley NT. Regulatory CD4+T cells and the control of autoimmune disease. Curr Opin Immunol 2004; 16: 695–701
   PubMed Web of Science ®Google Scholar
• Burchill MA, Goetz CA, Prlic M, O'Neil JJ, Harmon IR, Bensinger SJ, Turka LA, Brennan P, Jameson SC, Farrar MA. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: Development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J Immunol 2003; 171: 5853–5864
   PubMedGoogle Scholar
• Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004; 4: 665–674
   PubMed Web of Science ®Google Scholar
• Nelson BH, Willerford DM. Biology of the interleukin-2 receptor. Adv Immunol 1998; 70: 1–81
   PubMed Web of Science ®Google Scholar
• Van Parijs L, Biuckians A, Ibragimov A, Alt FW, Willerford DM, Abbas AK. Functional responses and apoptosis of CD25 (IL-2R alpha)-deficient T cells expressing a transgenic antigen receptor. J Immunol 1997; 158: 3738–3745
   PubMedGoogle Scholar
• Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998; 8: 615–623
   PubMed Web of Science ®Google Scholar
• Malek TR. The main function of IL-2 is to promote the development of T regulatory cells. J Leukoc Biol 2003; 74: 961–965
   PubMed Web of Science ®Google Scholar
• Snow JW, Abraham N, Ma MC, Herndier BG, Pastuszak AW, Goldsmith MA. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice. J Immunol 2003; 171: 5042–5050
   PubMedGoogle Scholar
• Krysko DV, D'Herde K, Vandenabeele P. Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 2006; 11: 1709–1726
   PubMed Web of Science ®Google Scholar
• Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886–897
   PubMed Web of Science ®Google Scholar
• Ferguson TA, Green DR, Griffith TS. Cell death and immune privilege. Int Rev Immunol 2002; 21: 153–172
   PubMedGoogle Scholar
• Viorritto IC, Nikolov NP, Siegel RM. Autoimmunity versus tolerance: Can dying cells tip the balance?. Clin Immunol 2007; 122: 125–134
   PubMed Web of Science ®Google Scholar